BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,052 | +15.4% | 32,083 | -4.8% | 1.93% | +2.4% |
| Q2 2023 | $20,846 | +21.1% | 33,683 | +26.7% | 1.88% | +30.4% |
| Q1 2023 | $17,209 | +173.8% | 26,583 | +61.5% | 1.44% | +214.1% |
| Q4 2022 | $6,285 | -99.9% | 16,458 | 0.0% | 0.46% | -7.3% |
| Q3 2022 | $7,365,000 | +9.5% | 16,458 | 0.0% | 0.50% | +3.1% |
| Q2 2022 | $6,726,000 | -40.0% | 16,458 | -28.3% | 0.48% | -34.0% |
| Q1 2022 | $11,209,000 | – | 22,958 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 52,257,000 | $39,745,106 | 8.72% |
| Context Capital Management, LLC | 32,083 | $24,052 | 1.93% |
| BRAIDWELL LP | 67,294,000 | $50,470,500 | 1.60% |
| DeepCurrents Investment Group LLC | 17,855,000 | $13,514,056 | 0.59% |
| Aequim Alternative Investments LP | 20,000,000 | $15,000,000 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,488,000 | $22,116,000 | 0.51% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $3,750,375 | 0.51% |
| ARISTEIA CAPITAL, L.L.C. | 25,280,000 | $18,960,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 8,217,000 | $6,121,665 | 0.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,604,000 | $3,430,520 | 0.49% |